Hyderabad: Biocon Ltd, India’s largest biotechnology company, on Thursday, December 24, said it has launched the generic version of US-based Gilead Sciences Inc.’s hepatitis-C drug Harvoni in the Indian market. Harvoni, the fixed-dose combination of ledipasvir-sofosbuvir […]